JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向：激光 经验分享：提交了以后需要每个作者通过邮件里面的网址确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0 经验分享：不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544309, encodeId=da91544309ba, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569612, encodeId=91e956961256, content=四个月，从投稿到接受！非常迅速，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QyEvfD6W5LGl64DdkkX1Ekk0eo4c5kXNeX8THumx0rroWHS3bGvNiccRlQhg2v05BgTvNS6hFob6T9AScSthPMw/132, createdBy=5ca12026302, createdName=xiaodon, createdTime=Tue Apr 16 00:00:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2023-12-10 ms9000001314913623 来自山西省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：投稿后建议修改为research letter，各位同仁怎么看

31 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向：激光 经验分享：提交了以后需要每个作者通过邮件里面的网址确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0 经验分享：不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544309, encodeId=da91544309ba, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569612, encodeId=91e956961256, content=四个月，从投稿到接受！非常迅速，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QyEvfD6W5LGl64DdkkX1Ekk0eo4c5kXNeX8THumx0rroWHS3bGvNiccRlQhg2v05BgTvNS6hFob6T9AScSthPMw/132, createdBy=5ca12026302, createdName=xiaodon, createdTime=Tue Apr 16 00:00:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2022-11-22 ms9000001195231403

请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～

128 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向：激光 经验分享：提交了以后需要每个作者通过邮件里面的网址确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0 经验分享：不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544309, encodeId=da91544309ba, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569612, encodeId=91e956961256, content=四个月，从投稿到接受！非常迅速，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QyEvfD6W5LGl64DdkkX1Ekk0eo4c5kXNeX8THumx0rroWHS3bGvNiccRlQhg2v05BgTvNS6hFob6T9AScSthPMw/132, createdBy=5ca12026302, createdName=xiaodon, createdTime=Tue Apr 16 00:00:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2022-05-31 中中y

提交4,5天了，还是submission to journal，有人知道这是啥情况嘛

173 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向：激光 经验分享：提交了以后需要每个作者通过邮件里面的网址确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0 经验分享：不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544309, encodeId=da91544309ba, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569612, encodeId=91e956961256, content=四个月，从投稿到接受！非常迅速，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QyEvfD6W5LGl64DdkkX1Ekk0eo4c5kXNeX8THumx0rroWHS3bGvNiccRlQhg2v05BgTvNS6hFob6T9AScSthPMw/132, createdBy=5ca12026302, createdName=xiaodon, createdTime=Tue Apr 16 00:00:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2022-11-09 ms1000000155957628

请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶

130 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向：激光 经验分享：提交了以后需要每个作者通过邮件里面的网址确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0 经验分享：不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544309, encodeId=da91544309ba, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569612, encodeId=91e956961256, content=四个月，从投稿到接受！非常迅速，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QyEvfD6W5LGl64DdkkX1Ekk0eo4c5kXNeX8THumx0rroWHS3bGvNiccRlQhg2v05BgTvNS6hFob6T9AScSthPMw/132, createdBy=5ca12026302, createdName=xiaodon, createdTime=Tue Apr 16 00:00:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2022-11-08 ms1000000155957628

请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项

127 0

[GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向：激光 经验分享：提交了以后需要每个作者通过邮件里面的网址确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0 经验分享：不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544309, encodeId=da91544309ba, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569612, encodeId=91e956961256, content=四个月，从投稿到接受！非常迅速，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QyEvfD6W5LGl64DdkkX1Ekk0eo4c5kXNeX8THumx0rroWHS3bGvNiccRlQhg2v05BgTvNS6hFob6T9AScSthPMw/132, createdBy=5ca12026302, createdName=xiaodon, createdTime=Tue Apr 16 00:00:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2022-10-30 ms4000000613289763

请问投稿10天状态直接变成Decession in process，是要被拒稿了吗

136 0

[GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向：激光 经验分享：提交了以后需要每个作者通过邮件里面的网址确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0 经验分享：不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544309, encodeId=da91544309ba, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569612, encodeId=91e956961256, content=四个月，从投稿到接受！非常迅速，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QyEvfD6W5LGl64DdkkX1Ekk0eo4c5kXNeX8THumx0rroWHS3bGvNiccRlQhg2v05BgTvNS6hFob6T9AScSthPMw/132, createdBy=5ca12026302, createdName=xiaodon, createdTime=Tue Apr 16 00:00:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2022-06-13 起云

偏重的研究方向：激光
经验分享：提交了以后需要每个作者通过邮件里面的网址确认吗？

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向：激光 经验分享：提交了以后需要每个作者通过邮件里面的网址确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0 经验分享：不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544309, encodeId=da91544309ba, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569612, encodeId=91e956961256, content=四个月，从投稿到接受！非常迅速，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QyEvfD6W5LGl64DdkkX1Ekk0eo4c5kXNeX8THumx0rroWHS3bGvNiccRlQhg2v05BgTvNS6hFob6T9AScSthPMw/132, createdBy=5ca12026302, createdName=xiaodon, createdTime=Tue Apr 16 00:00:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2022-06-02 中中y

审稿速度:1.0
经验分享：不接受个案

167 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向：激光 经验分享：提交了以后需要每个作者通过邮件里面的网址确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0 经验分享：不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544309, encodeId=da91544309ba, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569612, encodeId=91e956961256, content=四个月，从投稿到接受！非常迅速，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QyEvfD6W5LGl64DdkkX1Ekk0eo4c5kXNeX8THumx0rroWHS3bGvNiccRlQhg2v05BgTvNS6hFob6T9AScSthPMw/132, createdBy=5ca12026302, createdName=xiaodon, createdTime=Tue Apr 16 00:00:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2017-07-16 13805560183

赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦

661 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226186, encodeId=6738122618619, content=偏重的研究方向：激光 经验分享：提交了以后需要每个作者通过邮件里面的网址确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Mon Jun 13 16:34:22 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224050, encodeId=cd711224050bd, content=审稿速度:1.0 经验分享：不接受个案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Thu Jun 02 15:05:20 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544309, encodeId=da91544309ba, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569612, encodeId=91e956961256, content=四个月，从投稿到接受！非常迅速，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QyEvfD6W5LGl64DdkkX1Ekk0eo4c5kXNeX8THumx0rroWHS3bGvNiccRlQhg2v05BgTvNS6hFob6T9AScSthPMw/132, createdBy=5ca12026302, createdName=xiaodon, createdTime=Tue Apr 16 00:00:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2019-04-16 xiaodon

四个月，从投稿到接受！非常迅速，感谢！

373 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务